tiprankstipranks
Takeda Pharmaceutical Company (DE:TKDA)
FRANKFURT:TKDA
Germany Market
TKDA
Takeda Pharmaceutical Company
RESEARCH TOOLSreports

Takeda Pharmaceutical Company (TKDA) Stock News & Sentiment

4 Followers
Takeda’s OBIZUR Surveillance Study: Real World Data That Could Steady TAK’s Growth
Premium
Company Announcements
Takeda’s OBIZUR Surveillance Study: Real World Data That Could Steady TAK’s Growth
9h ago
TAK
Takeda Advances Pediatric Bleeding Disorder Program With New Vonicog Alfa Study Update
Premium
Company Announcements
Takeda Advances Pediatric Bleeding Disorder Program With New Vonicog Alfa Study Update
2d ago
TAK
Takeda Backs Real‑World Fruquintinib Study in Metastatic Colorectal Cancer
Premium
Company Announcements
Takeda Backs Real‑World Fruquintinib Study in Metastatic Colorectal Cancer
7d ago
TAK
Takeda’s Replagal Trial in India: Fresh Clinical Update With Rare Disease Upside
Premium
Company Announcements
Takeda’s Replagal Trial in India: Fresh Clinical Update With Rare Disease Upside
8d ago
TAK
Takeda’s Real-World CMV Study in Argentina Reaches Key Milestone
Premium
Company Announcements
Takeda’s Real-World CMV Study in Argentina Reaches Key Milestone
21d ago
TAK
Takeda Targets China PV Market With New Rusfertide Trial
Premium
Company Announcements
Takeda Targets China PV Market With New Rusfertide Trial
28d ago
TAK
Analyst Raises Price Target to ¥6,800 and Reiterates Buy on Strong Drug Performance, Pipeline Upside, and Long-Term Growth Drivers
Premium
Ratings
Analyst Raises Price Target to ¥6,800 and Reiterates Buy on Strong Drug Performance, Pipeline Upside, and Long-Term Growth Drivers
30d ago
TAK
More DE:TKDA News >

TKDA News on the Web

Morgan Stanley Remains a Buy on Takeda Pharmaceutical Co (TKPHF)
TipRanks News
Bullish
Protagonist Therapeutics price target raised to $190 from $178 at BMO Capital
TipRanks News
Neutral
Inventiva Names Chris Benecchi As COO Ahead Of Lanifibranor's Phase 3 Readout
rttnews
Neutral
Protagonist announces Takeda received U.S. FDA approval for MIMRYLO
TipRanks News
Bullish
FDA Approves Takeda's Mimrylo For Rare Blood Disorder Polycythemia Vera
rttnews
Bullish
Takeda receives FDA approval of NDA for Mimrylo
TipRanks News
Bullish
Can Keros Therapeutics (KROS)’s $20M Takeda Pharmaceutical Company Limited (TAK) Milestone Unlock a Billion-Dollar Opportunity?
Insider Monkey
Bullish
Top Takeda Executives Quietly Unload Significant Stakes in Major Stock Move
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
DE:TKDA
Sector Average
Media Buzz
This Week5 articles
Weekly Average7 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:TKDA’s Media Buzz Sentiment?
5 articles about DE:TKDA were published this week. In an average week, 7 articles are published.
    What is DE:TKDA’s weekly average amount of articles?
    In an average week, 7 articles about DE:TKDA are published.
      What is DE:TKDA’s News Sentiment?
      100% of articles about DE:TKDA were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        KURAKura Oncology
        AXGNAxoGen
        IRONDisc Medicine
        XERSXeris Pharmaceuticals
        LFSTLifestance Health Group
        Showing the stocks with the most bullish news sentiment over the past week